KayakerBc ,  true to all your points, however constellation pharma got a $1.7 Billion USD deal with far less clinical data and I am pretty  sure not as compelling data as Zen3694 trials, (I believe) .  You also stated you believe if a buyout deal occurred you don't think it would be distributed among the shareholders. DM ,wong are in their mid 60's.i don't think they want to wait 10years longer to get a return on their investment as well as Eastern and Hepalink and Newsoara. I think the insider have an exit strategy for a BP to take it all and move on. IMO....